ITGB3 and nasopharyngeal carcinoma: To test this possibility, cell viability of NPC cells was detected by the CCK-8 assay, and the results indicated that P-EVs treatment and ITGB3 overexpression increased the viability of NPC cells, but this enhancement was abolished by cilengitide and ITGB3 knockout (Figure 3C).